MSE
ALNY icon

MUFG Securities EMEA’s Alnylam Pharmaceuticals ALNY Stock Holding History

MUFG Securities EMEA’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Buy
+6,758
New +$2.04M 0.02% 328
2026
Q1 		– Sell
-15,000
Closed -$5.96M – 553
2025
Q4 		$5.96M Buy
+15,000
New +$6.64M 0.07% 185

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MUFG Securities EMEA's ALNY Position: Q2 2026 in Review

MUFG Securities EMEA opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 6,758 shares worth $2.03M. The stake represents 0.02% of the portfolio and ranks #328 among its holdings. This is a return to the name: MUFG Securities EMEA previously reported a position in ALNY as recently as Q4 2025.

MUFG Securities EMEA first reported a position in ALNY in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.96M in Q4 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • MUFG Securities EMEA held 6,758 shares of Alnylam Pharmaceuticals worth $2.03M as of Q2 2026.
  • Alnylam Pharmaceuticals was a new MUFG Securities EMEA position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.02% of MUFG Securities EMEA's portfolio in Q2 2026, its #328 holding.
  • MUFG Securities EMEA first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • MUFG Securities EMEA's Alnylam Pharmaceuticals position peaked at $5.96M in Q4 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.